Coagulation Analyzers Market: Current Analysis and Forecast (2021-2027)
Emphasis on Product Type (Analyzers, Clinical laboratory analyzers, Point-of-care and consumables, Others); Test Type (Prothrombin time testing, Fibrinogen testing, Activated clotting time testing, Activated partial thromboplastin time testing, D-dimer testing, Platelet function tests, , Other coagulation tests); Technology (Optical technology, Mechanical technology, Electrochemical technology, Other technologies); Region/Country (North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World)
Coagulation Analyzers Market is anticipated display a CAGR of around XX% over the forecast period (2021-2027). The global Coagulation Analyzers market is expected to witness robust growth mainly due to rising prevalence of cardiac diseases and blood disorders like thromboembolic disease and bleeding disorders such as impaired liver function, hemophilia, and von Willebrand disease. Moreover, the increase in the availability of more advanced analyzers, growing awareness about these diseases and their management, rising geriatric population base are some of the factors likely to boost the Global Coagulation Analyzers Market during the forecast period. In addition, rise in research and development expenditure by key market players and their focus on the launch and approval of new devices & instrument, is further expected to propel the market growth.
The ongoing COVID-19 pandemic across the world have had a tremendous impact on different spectra of society, the market for Coagulation Analyzers no less. The market for Coagulation Analyzers faced a positive impact due to movement of bulk need, and there has been a huge incline in the hospital and clinics visits. Due to this, there has been a positive impact on the product sales and supply chains of numerous sectors, particularly during the first two quarters of the year 2020. This has adversely affected the trade of Coagulation Analyzers products due to the high demand and widespread financial distress.
Insights Presented in the Report
“Amongst Test Type, Prothrombin Time Testing segment dominated the market in 2020”
Based on test type, the Coagulation Analyzers Market is segmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimer testing, platelet function tests, other coagulation Tests. In 2020, Prothrombin Time Testing category dominated the market. This is mainly due to the rising geriatric population coupled with unhealthy lifestyle and hormonal imbalance across the globe.
“Amongst End User, Diagnostic Centers category to witness fastest growth rate”
Based on End User, the market is bifurcated into the market is bifurcated into hospitals and clinics, diagnostic centers, research institutes and others. In 2020, Diagnostic Centers category accounted for the majority share in the global market. Furthermore, the availability of advanced equipment, which has higher accuracy and features to perform multiple tests, is another vital driver for the growth. For instance, as per OCED, the government spending on healthcare in the United States was 8,032.6 USD per capita which increased to 9,386.5 USD per capita in 2019. Furthermore, the presence of well-established infrastructure in hospitals, better reimbursement policies, and availability of advanced technologies and well-trained healthcare professionals is also one of the main reasons why patients prefer hospitals & clinics for wound care.
“North America will Dominate the Market During the Forecast Period”
For a better understanding of the demand of Coagulation Analyzers Market, the market is analyzed for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Currently, North America dominated the market in 2020; however, Asia-Pacific is expected to witness highest CAGR growth owing to rising healthcare expenditure in countries such as China, India, and other developing Asian countries. Some of the major players operating in the market include Abbott Laboratories Inc., Danaher, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Nihon Kohden Corporation, Maccura Biotechnology Co., Ltd., Bio-Group Medical System.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
The Coagulation Analyzers Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Analyzing the historical market, estimation of the current market, and forecasting the future of the Coagulation Analyzers Market were the three major steps undertaken to create and analyze the demand and sales of Coagulation Analyzers across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted, with industry experts across the value chain of the industry. Post assumption and validation of market numbers through primary interviews, we employed a bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below.
Seek More Details About Research Methodology
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detailed secondary study was conducted to obtain the historical market size of the Coagulation Analyzers through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Coagulation Analyzers, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are product type, test type, technology, end user and regions. Further regional level analyses were conducted to evaluate the overall demand of Coagulation Analyzers in global context.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size. Further, we conducted factor analysis using dependent and independent variables such as industry trends, product application, understanding consumer demands, competitive landscape, brand positioning and pricing analysis. Historical trends and their year-on-year impact on the market size and share was analyzed. Demand and supply side scenario was also thoroughly studied.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Market, and market shares of the segments and company. All the required percentage split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (US$) and the demand of Coagulation Analyzers across the major regions globally
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the Coagulation Analyzers Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major countries. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Coagulation Analyzers market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of by product type, by test type, by technology, end user and regions.
The main objective of the Coagulation Analyzers Market Study
The current & future market trends of the Coagulation Analyzers Market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of Coagulation Analyzers in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments of the industry
- Segments in the study include product type, test type, technology, end user and regions
- Defined analysis of the regulatory framework for the Coagulation Analyzers industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors pertaining to the industry
- Analyze the current and forecast market size of the Coagulation Analyzers across the globe. Major regions analyzed in the report include North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Define and analyze the competitive landscape of the Coagulation Analyzers sector and the growth strategies adopted by the market players to sustain in the fast-growing market
Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
